Innovative strategies to advance severe TBI treatment
Until the advent of the successful CAPTAIN-trials with Cerebrolysin, one of the most important unmet needs in medicine has been the treatment of severe and moderate traumatic brain injury with evidence-based pharmacological agents.
Our speakers will present to you with innovative preclinical and clinical treatment concepts for severe TBI patients, innovative educational programs focusing on this highly complex medical problem and innovative biometric approaches solving the historical trial design failures in TBI trials.
Johannes C. VesterHead Biometry & Clinical Research
IDV Data Analysis and Study Planning, Gauting, Germany
Helmut TrimmelHead of Anaesthesia, Emergency and General Intensive Care Medicine
Landesklinikum Wiener Neustadt, Austria
Ignacio J. PreviglianoHospital General de Agudos J. A. Fernández
Buenos Aires City – Argentina
Peter LacknerHead of Department of Neurology, Clinic Floridsdorf, Vienna, Austria
This webinar is hosted by
Johannes C. Vester
Head Biometry & Clinical Research<br /> IDV Data Analysis and Study Planning, Gauting, Germany
New vistas in TBI clinical research - on the way towards a new gold standard
by Johannes C. Vester
Best supportive care in TBI: new hope from combined neuroprotective agents?
by Helmut Trimmel
Post Intensive Care Syndrome: neurotrophic factor hypothesis
by Ignacio J. Previgliano
Innovative concepts for increasing awareness of multidisciplinary treatment after TBI.
by Peter Lackner